PT Antam Reports Unchanged CDI and Share Count for October 2026

Aditi Sarkar

04 November 2026 12:53 PM AEDT

PT Antam Reports Unchanged CDI and Share Count for October 2026

Image Source: Krish Capital Pty Ltd

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

PT Antam (Persero) Tbk (ASX:ATM) has lodged its monthly Appendix 4A statement of CHESS Depositary Interests on issue, disclosing that the total number of CDIs and underlying securities remained unchanged at the end of October 2026 compared to the previous month.

Key Points

Total CDIs on issue over quoted securities held at 1,303,649 at end of October 2026, unchanged from the prior month.
Common B Class Shares (ATMAA) totalled 24,030,764,725 at month end, with no net change from the previous month.
ATMAB securities, representing 1:5 CDI equivalents to ATMAA, totalled 4,806,152,945, also unchanged from the prior month.
ATM CDIs carry a ratio of 1:5, as stated in the filing.

October 2026 CDI Statement Details

According to the filing lodged on 4 November 2026, PT Antam (Persero) Tbk reported its Appendix 4A statement covering October 2026. The total number of CHESS Depositary Interests issued over quoted securities under ASX security code ATM stood at 1,303,649 at the end of the statement month. This figure was identical to the total recorded at the end of the previous month, resulting in a net difference of zero. The CDIs carry a ratio of 1:5, as disclosed in the filing.

Underlying Common B Class Share Count

The filing disclosed that the total number of Common B Class Shares (ATMAA) on issue at the end of October 2026 was 24,030,764,725. This was equal to the total recorded at the end of the previous month, with a net difference of zero. These securities represent the class of underlying shares over which CDIs have not been issued, as reported under Part 2 of the Appendix 4A statement submitted by the company to the ASX.

ATMAB Securities Remain Stable at Month End

PT Antam also disclosed the number of ATMAB securities on issue, described in the filing as 1:5 CDI equivalents to ATMAA. The total at the end of October 2026 was 4,806,152,945, unchanged from the total recorded at the end of the previous month, with a net difference of zero. The filing confirms that where total CDIs exceed those for which listing fees have previously been paid, the entity applies for quotation of the relevant securities under ASX Listing Rules, as outlined in the standard Appendix 4A disclosure requirements.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.